BioAge Labs, Current Valuation vs. EBITDA
| BIOA Stock | 19.29 0.41 2.08% |
For BioAge Labs, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioAge Labs, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioAge Labs, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioAge Labs,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioAge Labs, over time as well as its relative position and ranking within its peers.
BioAge |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioAge Labs, EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioAge Labs,'s current stock value. Our valuation model uses many indicators to compare BioAge Labs, value to that of its competitors to determine the firm's financial worth. BioAge Labs, is rated below average in current valuation category among its peers. It is rated below average in ebitda category among its peers . At present, BioAge Labs,'s EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioAge Labs,'s earnings, one of the primary drivers of an investment's value.BioAge EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BioAge Labs, |
| = | 539.05 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
BioAge Labs, |
| = | (45.81 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
BioAge EBITDA Comparison
BioAge Labs, is currently under evaluation in ebitda category among its peers.
BioAge Labs, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioAge Labs,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioAge Labs, will eventually generate negative long term returns. The profitability progress is the general direction of BioAge Labs,'s change in net profit over the period of time. It can combine multiple indicators of BioAge Labs,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 164 K | 172.2 K | |
| Operating Income | -48.4 M | -50.8 M | |
| Income Before Tax | -63.9 M | -67 M | |
| Total Other Income Expense Net | -15.5 M | -14.7 M | |
| Net Loss | -63.9 M | -67 M | |
| Income Tax Expense | 7.8 M | 8.2 M | |
| Net Interest Income | -5.4 M | -5.1 M | |
| Interest Income | 2.4 M | 1.6 M | |
| Net Loss | -63.9 M | -67 M | |
| Net Loss | (2.11) | (2.21) | |
| Income Quality | 0.59 | 0.89 | |
| Net Income Per E B T | 1.11 | 1.02 |
BioAge Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioAge Labs,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioAge Labs, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioAge Labs,'s important profitability drivers and their relationship over time.
Use BioAge Labs, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioAge Labs, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAge Labs, will appreciate offsetting losses from the drop in the long position's value.BioAge Labs, Pair Trading
BioAge Labs, Pair Trading Analysis
The ability to find closely correlated positions to BioAge Labs, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioAge Labs, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioAge Labs, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioAge Labs, to buy it.
The correlation of BioAge Labs, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioAge Labs, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioAge Labs, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioAge Labs, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioAge Labs, position
In addition to having BioAge Labs, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Measuring and Control Equipment Thematic Idea Now
Measuring and Control Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Measuring and Control Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Measuring and Control Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
To fully project BioAge Labs,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioAge Labs, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioAge Labs,'s income statement, its balance sheet, and the statement of cash flows.